Tom Jones

Baillie Gifford & Co. is an independent, global investment management firm headquartered in Edinburgh, UK. The firm was founded in 1908 and is wholly-owned by their partners. Baillie Gifford manages assets for pension funds, institutions, corporates, foundations, charities and retail investors. They are a socially responsible investor which works with their fund managers to assess ESG concerns both before and after investing in companies.

Ruffer LLP is the investment management subsidiary of Ruffer Management Ltd. in Great Britain. The firm was founded as Ruffer Investment Management Ltd. in 1994 by Jonathan Ruffer, Jane Tufnell, and Earl Ferrers. In 2004, they transferred their investment business to Ruffer LLP. Headquartered in London, Ruffer manages assets and funds on a discretionary basis for private and institutional clients including trusts, charities, pension funds, family offices, corporations, investment companies and insurance companies. Ruffer is a responsible investor that fully integrates environmental, social and corporate governance (ESG) issues into their investment process.

BlackRock Investment Management (UK) Ltd. (BIM-UK) is an investment management firm headquartered in London, UK. The firm is a subsidiary of BlackRock Finance Europe Ltd., ultimately owned by BlackRock, Inc. (NYSE: BLK) in the US. BIM-UK was founded in 2006 following the merger of Merrill Lynch Investment Managers and BlackRock. In 2009, BlackRock merged with Barclays Global Investors, including the iShares exchange traded funds business. The combined firm operates under the BlackRock name and has retained the iShares brand. BIM-UK manages a family of mutual funds and acts as sub-advisor to other mutual and pension funds. They also offer alternative investments and managed accounts for individual and institutional clients.

Puma Private Equity Ltd. (Puma Private Equity) is a private equity subsidiary of Puma Investment Management Ltd. founded in 2018. The firm is headquartered in London.

Puma Investment Management Ltd (Puma Investment) is a private equity firm founded in 1985. The firm is headquartered in London with additional offices in Liverpool and Edinburgh.

Arceau Capital Ltd (Arceau Capital) is a venture capital firm founded in 2020 by Louis D'Origny. The firm is headquartered in Miami, Florida.

Ark UK Group Ltd. is a private company that provides building services in Surrey, Hampshire, and Berkshire. The company is based in Warwick, UK, and has subsidiaries in the Netherlands and the United Kingdom. The British company has fully certified tradesmen, including electricians, plumbers, heating and alarm engineers, and maintenance staff. The company can be contacted at 01276 300222. The company was founded in 1997 and offers top-notch services.

Part of Ark UK Group Ltd., Ark UK Holdings Ltd. is a holding company that operates subsidiaries specializing in home improvement and garden care stores. The company is based in London, UK and was founded in 2019.

Part of Ark UK Group Ltd., Homebase (UK & I) Holdings Ltd. is a holding company that operates subsidiaries retailing home improvement and gardening products. The company is based in London, UK and was founded in 2016.

Part of HUK 70 Ltd., OO Retail Ltd. functions as an investment holding British company. The company is based in London, UK and was founded in 2016.

HUK 70 Ltd. is a British investment company founded in 2016. The private company operates as an investment firm.

Filefigure Ltd. operates as a holding company. The company was founded on June 8, 2000 and is headquartered in London, the United Kingdom.

Formulaattori Oy is a Finnish company that provides a solution called Formulator, which simplifies case formulation for mental health professionals and clients. The company is based in Espoo, Finland. The solution uses a standardized, science-based approach to automate the patient's first step, making the process faster and easier to achieve results. The company was founded in 2021, and the CEO is Niklas Nordling.

LIfT BioSciences Ltd. is a pre-clinical stage biotech company based in Brighton, UK. LIfT BioSciences is developing a first-in-class alpha neutrophil cell therapy called N-Lift, which is produced from a patented process using exceptional stem cells, a proprietary enhancement media, and genetic engineering. The therapy is designed to destroy solid tumors both directly and indirectly by turning the tumor microenvironment against the tumor and recruiting the rest of the immune system to destroy it. The British company is working with a range of pharmaceutical license partners across oncology, immunology, neurology, and AMR to develop a portfolio of immune-modulatory alpha neutrophils for treating a range of therapeutic indications, including solid tumors. The company's goal is to deliver complete remission in high unmet need solid tumors before the decade is out. The company was founded in 2014 by Alexander William Blyth, who was inspired to create the company after his mother passed away from pancreatic cancer.

Part of Gas Sensing Solutions Ltd., Cambridge Respiratory Innovations Ltd. develops and manufactures medical devices. The private company is based in Swavesey, UK.

Nina Capital SGEIC SA (Nina Capital) is a venture capital firm founded in 2019 by Marta Gaia Zanchi. It is headquartered in Barcelona, Spain.

contextflow GmbH provides a search engine which allows radiologists to search for visually similar images from a hospital's database. It provides technology for radiologists, radiology departments, hospital groups, university hospitals and also for the extension for existing image archives. The company was founded by Markus Holzer and is headquartered in Vienna, Austria.

EarlySight SA engages in the development, production, and marketing of imaging solutions for the medical and life science sectors. It focuses primarily on the development of an eye camera for the monitoring of the tissue degenerative process associated with retinal diseases. The company was founded by Timothé Laforest, Mathieu Kunzi, Christophe Moser, and Francine Behar-Cohen in 2019 and is headquartered in Lausanne, Switzerland.

Neucruit Ltd. develops a patient management platform for the healthcare industry. The company is based in London, UK. The British company was founded in 2019. Livia Ng has been the CEO of the company since 2019.

Oakley Capital Ltd. (Private Equity) (Oakley Capital) is a private equity firm, a subsidiary of Oakley Capital Ltd. founded in 2002 by Peter Adam Daiches Dubens and David John Till. The firm is headquartered in London.

Segmed, Inc. is a biotechnology firm which provides cloud-based platform for medical companies. It helps in acceleration and development of medical AI algorithms by providing companies and research groups with access to training datasets. The company was founded by Cailin Hardell, Adam Koszek, and Martin Willemink and is headquartered in Menlo Park, CA.

Downing Ventures (Downing Ventures) is an independent venture capital firm founded in 1986. The firm is headquartered in London.

Part of Starwood Property Trust, Inc., Situs International Ltd. acquires, develops, repositions, manages and sells commercial and multi-family residential real estate properties. The company is based in London, UK.

G Square Healthcare Private Equity LLP (G Square Healthcare) is a private equity firm founded in 2008 by Laurent Gerard Ganem. The firm is headquartered in London, United Kingdom.

Nordic Capital Ltd. (Nordic Capital) is a private equity subsidiary of Triona Holding SA founded in 1989 by Robert Andreen and Morgan Olsson. The firm is headquartered in St Hellier, New Jersey.

Qkine Ltd. provides growth factors and bioactive proteins for use in stem cell science and regenerative medicine applications. Its products include Activin A and FGF2. The firm specializes in protein purification, organoids, cytokines, and protein-engineering. The company was founded by Marko Hyvonen and Catherine Elton in 2016 and is headquartered in Cambridge, the United Kingdom.

Franklin Advisers, Inc. is a mutual fund manager and registered investment advisor headquartered in San Mateo, California. The firm was founded in 1985 and is a subsidiary of Franklin Resources, Inc. (NYSE: BEN), a holding company that, together with its various subsidiaries is referred to as Franklin Templeton Investments. Franklin Advisers provides investment advisory and portfolio management services to US and non-US, registered open-end and closed-end funds and unregistered funds, as well as separate accounts.

Aubrey Capital Management Ltd. (ACM) is an investment management firm headquartered in Edinburgh, UK with additional office in London. The firm was founded in 2006 as DMWS 767 Ltd. They are a subsidiary of Treetop Asset Management SA in Luxembourg. ACM provides discretionary investment services for private individuals, family groups, trusts, charities and pensions.

Close Asset Management Ltd. (Close AM) is the asset management subsidiary of Close Asset Management Holdings Ltd., itself a subsidiary of Close Brothers Group plc (LSE: CBG, ADR: CBGPY) in Great Britain. The firm was founded in 1982 and does business as Close Brothers Asset Management. Headquartered in London, Close AM provides a bespoke investment management service to private clients, trusts and corporates.

Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.

Monograph Capital Advisors (UK) LLP (Monograph Capital) is a private equity and venture capital firm founded in 2021 by Fred Ehrenkranz Cohen and Charles Conn. The firm is headquartered in London, GB.

Ascend Gene & Cell Therapies Ltd. is a gene and cell therapy manufacturing specialist that aims to create effective gene therapies to a world-class standard. The company is based in Altrincham, UK, and has subsidiaries in Germany. The British company focuses on constantly refining and flexing their approach and embracing opportunities to innovate to create therapies that change lives. Ascend has over $130m of funding as expert teams merge. The company has a solid platform that allows their team to do their best work and deliver unwavering quality. Timothy Michael Funnell has been the CEO of the company since 2021.

Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom.